Cannabis & Mental Health: A new India-based study comparing new-onset psychosis tied to confirmed cannabis exposure vs non-cannabis psychosis found better cognitive gains and symptom improvements after 4 weeks of inpatient treatment in the cannabis-associated psychosis group. Sleep & Consumer Claims: An AASM survey reports 64% of cannabis consumers say it helps them sleep, while also flagging risks like daytime sleepiness and impaired driving. Policy & Market Pressure: The National Restaurant Association is urging Congress to delay a ban on hemp-derived THC drinks, asking for a clear federal regulatory framework (age checks, labeling, dosing, impairment standards). Industry Scrutiny: A Lancet Psychiatry study argues that removing criminal penalties doesn’t necessarily raise overall cannabis use, but commercial markets may drive more potent products and higher addiction risk. Product/Ad Reality Check: A CBD outreach piece warns brands face near-total ad blackouts on Google, Meta, and TikTok, pushing “guest posts” that can trigger penalties if they look like paid link schemes. Safety/Enforcement: A drug-affected driver in Australia was fined and disqualified after mounting a roundabout and crashing; cannabis was found in his system. Access Gap: A Cook Islands letter says medicinal cannabis laws still leave residents unable to fill prescriptions locally, forcing repeated travel abroad.